Canada's National Research Council (NRC) announced on Tuesday that it will cooperate with China's kangxinuo biology Co., Ltd. to conduct a second round of human clinical trials in Canada this autumn and a large number of vaccine manufacturing in Canada in the future, Canadian media reported on May 12. It is reported that the vaccine was jointly developed by academician Chen Wei of the Chinese Academy of Military Sciences and China kangxinuo biological Co., Ltd., and it is also one of the first five candidate vaccines to enter clinical trials in the world. The report pointed out that this is a highly effective vaccine research and development project launched by China and Canada again.
Hot Model No.: